Drugs for Duchenne Muscular Dystrophy and Forecast Market
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Drugs for Duchenne Muscular Dystrophy (DMD)
1.2 Key Market Segments
1.2.1 Drugs for Duchenne Muscular Dystrophy (DMD) Segment by Type
1.2.2 Drugs for Duchenne Muscular Dystrophy (DMD) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Drugs for Duchenne Muscular Dystrophy (DMD) Market Overview
2.1 Global Market Overview
2.1.1 Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Drugs for Duchenne Muscular Dystrophy (DMD) Market Competitive Landscape
3.1 Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales by Manufacturers (2019-2025)
3.2 Global Drugs for Duchenne Muscular Dystrophy (DMD) Revenue Market Share by Manufacturers (2019-2025)
3.3 Drugs for Duchenne Muscular Dystrophy (DMD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Drugs for Duchenne Muscular Dystrophy (DMD) Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Drugs for Duchenne Muscular Dystrophy (DMD) Sales Sites, Area Served, Product Type
3.6 Drugs for Duchenne Muscular Dystrophy (DMD) Market Competitive Situation and Trends
3.6.1 Drugs for Duchenne Muscular Dystrophy (DMD) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Drugs for Duchenne Muscular Dystrophy (DMD) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Drugs for Duchenne Muscular Dystrophy (DMD) Industry Chain Analysis
4.1 Drugs for Duchenne Muscular Dystrophy (DMD) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Drugs for Duchenne Muscular Dystrophy (DMD) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Drugs for Duchenne Muscular Dystrophy (DMD) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales Market Share by Type (2019-2025)
6.3 Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type (2019-2025)
6.4 Global Drugs for Duchenne Muscular Dystrophy (DMD) Price by Type (2019-2025)
7 Drugs for Duchenne Muscular Dystrophy (DMD) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Sales by Application (2019-2025)
7.3 Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size (M USD) by Application (2019-2025)
7.4 Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales Growth Rate by Application (2019-2025)
8 Drugs for Duchenne Muscular Dystrophy (DMD) Market Consumption by Region
8.1 Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales by Region
8.1.1 Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales by Region
8.1.2 Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales Market Share by Region
8.2 North America
8.2.1 North America Drugs for Duchenne Muscular Dystrophy (DMD) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Drugs for Duchenne Muscular Dystrophy (DMD) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Drugs for Duchenne Muscular Dystrophy (DMD) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Drugs for Duchenne Muscular Dystrophy (DMD) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Drugs for Duchenne Muscular Dystrophy (DMD) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Drugs for Duchenne Muscular Dystrophy (DMD) Market Production by Region
9.1 Global Production of Drugs for Duchenne Muscular Dystrophy (DMD) by Region (2019-2025)
9.2 Global Drugs for Duchenne Muscular Dystrophy (DMD) Revenue Market Share by Region (2019-2025)
9.3 Global Drugs for Duchenne Muscular Dystrophy (DMD) Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Drugs for Duchenne Muscular Dystrophy (DMD) Production
9.4.1 North America Drugs for Duchenne Muscular Dystrophy (DMD) Production Growth Rate (2019-2025)
9.4.2 North America Drugs for Duchenne Muscular Dystrophy (DMD) Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Drugs for Duchenne Muscular Dystrophy (DMD) Production
9.5.1 Europe Drugs for Duchenne Muscular Dystrophy (DMD) Production Growth Rate (2019-2025)
9.5.2 Europe Drugs for Duchenne Muscular Dystrophy (DMD) Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Drugs for Duchenne Muscular Dystrophy (DMD) Production (2019-2025)
9.6.1 Japan Drugs for Duchenne Muscular Dystrophy (DMD) Production Growth Rate (2019-2025)
9.6.2 Japan Drugs for Duchenne Muscular Dystrophy (DMD) Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Drugs for Duchenne Muscular Dystrophy (DMD) Production (2019-2025)
9.7.1 China Drugs for Duchenne Muscular Dystrophy (DMD) Production Growth Rate (2019-2025)
9.7.2 China Drugs for Duchenne Muscular Dystrophy (DMD) Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Sarepta Therapeutics
10.1.1 Sarepta Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Basic Information
10.1.2 Sarepta Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Product Overview
10.1.3 Sarepta Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Product Market Performance
10.1.4 Sarepta Therapeutics Business Overview
10.1.5 Sarepta Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) SWOT Analysis
10.1.6 Sarepta Therapeutics Recent Developments
10.2 PTC Therapeutics
10.2.1 PTC Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Basic Information
10.2.2 PTC Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Product Overview
10.2.3 PTC Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Product Market Performance
10.2.4 PTC Therapeutics Business Overview
10.2.5 PTC Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) SWOT Analysis
10.2.6 PTC Therapeutics Recent Developments
10.3 Pfizer
10.3.1 Pfizer Drugs for Duchenne Muscular Dystrophy (DMD) Basic Information
10.3.2 Pfizer Drugs for Duchenne Muscular Dystrophy (DMD) Product Overview
10.3.3 Pfizer Drugs for Duchenne Muscular Dystrophy (DMD) Product Market Performance
10.3.4 Pfizer Drugs for Duchenne Muscular Dystrophy (DMD) SWOT Analysis
10.3.5 Pfizer Business Overview
10.3.6 Pfizer Recent Developments
10.4 Bristol-Myers Squibb
10.4.1 Bristol-Myers Squibb Drugs for Duchenne Muscular Dystrophy (DMD) Basic Information
10.4.2 Bristol-Myers Squibb Drugs for Duchenne Muscular Dystrophy (DMD) Product Overview
10.4.3 Bristol-Myers Squibb Drugs for Duchenne Muscular Dystrophy (DMD) Product Market Performance
10.4.4 Bristol-Myers Squibb Business Overview
10.4.5 Bristol-Myers Squibb Recent Developments
10.5 Italfarmaco
10.5.1 Italfarmaco Drugs for Duchenne Muscular Dystrophy (DMD) Basic Information
10.5.2 Italfarmaco Drugs for Duchenne Muscular Dystrophy (DMD) Product Overview
10.5.3 Italfarmaco Drugs for Duchenne Muscular Dystrophy (DMD) Product Market Performance
10.5.4 Italfarmaco Business Overview
10.5.5 Italfarmaco Recent Developments
10.6 Santhera Pharmaceuticals
10.6.1 Santhera Pharmaceuticals Drugs for Duchenne Muscular Dystrophy (DMD) Basic Information
10.6.2 Santhera Pharmaceuticals Drugs for Duchenne Muscular Dystrophy (DMD) Product Overview
10.6.3 Santhera Pharmaceuticals Drugs for Duchenne Muscular Dystrophy (DMD) Product Market Performance
10.6.4 Santhera Pharmaceuticals Business Overview
10.6.5 Santhera Pharmaceuticals Recent Developments
10.7 WaVe life Science
10.7.1 WaVe life Science Drugs for Duchenne Muscular Dystrophy (DMD) Basic Information
10.7.2 WaVe life Science Drugs for Duchenne Muscular Dystrophy (DMD) Product Overview
10.7.3 WaVe life Science Drugs for Duchenne Muscular Dystrophy (DMD) Product Market Performance
10.7.4 WaVe life Science Business Overview
10.7.5 WaVe life Science Recent Developments
11 Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast by Region
11.1 Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Forecast
11.2 Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Forecast by Country
11.2.3 Asia Pacific Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Forecast by Region
11.2.4 South America Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Drugs for Duchenne Muscular Dystrophy (DMD) by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Drugs for Duchenne Muscular Dystrophy (DMD) by Type (2025-2032)
12.1.2 Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Drugs for Duchenne Muscular Dystrophy (DMD) by Type (2025-2032)
12.2 Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast by Application (2025-2032)
12.2.1 Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales (K MT) Forecast by Application
12.2.2 Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Comparison by Region (M USD)
Table 5. Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Drugs for Duchenne Muscular Dystrophy (DMD) Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Drugs for Duchenne Muscular Dystrophy (DMD) Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Duchenne Muscular Dystrophy (DMD) as of 2022)
Table 10. Global Market Drugs for Duchenne Muscular Dystrophy (DMD) Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Drugs for Duchenne Muscular Dystrophy (DMD) Sales Sites and Area Served
Table 12. Manufacturers Drugs for Duchenne Muscular Dystrophy (DMD) Product Type
Table 13. Global Drugs for Duchenne Muscular Dystrophy (DMD) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Drugs for Duchenne Muscular Dystrophy (DMD)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Drugs for Duchenne Muscular Dystrophy (DMD) Market Challenges
Table 22. Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales by Type (K MT)
Table 23. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type (M USD)
Table 24. Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales (K MT) by Type (2019-2025)
Table 25. Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales Market Share by Type (2019-2025)
Table 26. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size (M USD) by Type (2019-2025)
Table 27. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Share by Type (2019-2025)
Table 28. Global Drugs for Duchenne Muscular Dystrophy (DMD) Price (USD/MT) by Type (2019-2025)
Table 29. Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales (K MT) by Application
Table 30. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application
Table 31. Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales by Application (2019-2025) & (K MT)
Table 32. Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales Market Share by Application (2019-2025)
Table 33. Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales by Application (2019-2025) & (M USD)
Table 34. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Share by Application (2019-2025)
Table 35. Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales Growth Rate by Application (2019-2025)
Table 36. Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales by Region (2019-2025) & (K MT)
Table 37. Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales Market Share by Region (2019-2025)
Table 38. North America Drugs for Duchenne Muscular Dystrophy (DMD) Sales by Country (2019-2025) & (K MT)
Table 39. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Drugs for Duchenne Muscular Dystrophy (DMD) Sales by Region (2019-2025) & (K MT)
Table 41. South America Drugs for Duchenne Muscular Dystrophy (DMD) Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Drugs for Duchenne Muscular Dystrophy (DMD) Sales by Region (2019-2025) & (K MT)
Table 43. Global Drugs for Duchenne Muscular Dystrophy (DMD) Production (K MT) by Region (2019-2025)
Table 44. Global Drugs for Duchenne Muscular Dystrophy (DMD) Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Drugs for Duchenne Muscular Dystrophy (DMD) Revenue Market Share by Region (2019-2025)
Table 46. Global Drugs for Duchenne Muscular Dystrophy (DMD) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Drugs for Duchenne Muscular Dystrophy (DMD) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Drugs for Duchenne Muscular Dystrophy (DMD) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Drugs for Duchenne Muscular Dystrophy (DMD) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Sarepta Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Basic Information
Table 52. Sarepta Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Product Overview
Table 53. Sarepta Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Sarepta Therapeutics Business Overview
Table 55. Sarepta Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) SWOT Analysis
Table 56. Sarepta Therapeutics Recent Developments
Table 57. PTC Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Basic Information
Table 58. PTC Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Product Overview
Table 59. PTC Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. PTC Therapeutics Business Overview
Table 61. PTC Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) SWOT Analysis
Table 62. PTC Therapeutics Recent Developments
Table 63. Pfizer Drugs for Duchenne Muscular Dystrophy (DMD) Basic Information
Table 64. Pfizer Drugs for Duchenne Muscular Dystrophy (DMD) Product Overview
Table 65. Pfizer Drugs for Duchenne Muscular Dystrophy (DMD) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Pfizer Drugs for Duchenne Muscular Dystrophy (DMD) SWOT Analysis
Table 67. Pfizer Business Overview
Table 68. Pfizer Recent Developments
Table 69. Bristol-Myers Squibb Drugs for Duchenne Muscular Dystrophy (DMD) Basic Information
Table 70. Bristol-Myers Squibb Drugs for Duchenne Muscular Dystrophy (DMD) Product Overview
Table 71. Bristol-Myers Squibb Drugs for Duchenne Muscular Dystrophy (DMD) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Bristol-Myers Squibb Business Overview
Table 73. Bristol-Myers Squibb Recent Developments
Table 74. Italfarmaco Drugs for Duchenne Muscular Dystrophy (DMD) Basic Information
Table 75. Italfarmaco Drugs for Duchenne Muscular Dystrophy (DMD) Product Overview
Table 76. Italfarmaco Drugs for Duchenne Muscular Dystrophy (DMD) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Italfarmaco Business Overview
Table 78. Italfarmaco Recent Developments
Table 79. Santhera Pharmaceuticals Drugs for Duchenne Muscular Dystrophy (DMD) Basic Information
Table 80. Santhera Pharmaceuticals Drugs for Duchenne Muscular Dystrophy (DMD) Product Overview
Table 81. Santhera Pharmaceuticals Drugs for Duchenne Muscular Dystrophy (DMD) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Santhera Pharmaceuticals Business Overview
Table 83. Santhera Pharmaceuticals Recent Developments
Table 84. WaVe life Science Drugs for Duchenne Muscular Dystrophy (DMD) Basic Information
Table 85. WaVe life Science Drugs for Duchenne Muscular Dystrophy (DMD) Product Overview
Table 86. WaVe life Science Drugs for Duchenne Muscular Dystrophy (DMD) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. WaVe life Science Business Overview
Table 88. WaVe life Science Recent Developments
Table 89. Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales Forecast by Region (2025-2032) & (K MT)
Table 90. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Forecast by Region (2025-2032) & (M USD)
Table 91. North America Drugs for Duchenne Muscular Dystrophy (DMD) Sales Forecast by Country (2025-2032) & (K MT)
Table 92. North America Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Forecast by Country (2025-2032) & (M USD)
Table 93. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Sales Forecast by Country (2025-2032) & (K MT)
Table 94. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Forecast by Country (2025-2032) & (M USD)
Table 95. Asia Pacific Drugs for Duchenne Muscular Dystrophy (DMD) Sales Forecast by Region (2025-2032) & (K MT)
Table 96. Asia Pacific Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Forecast by Region (2025-2032) & (M USD)
Table 97. South America Drugs for Duchenne Muscular Dystrophy (DMD) Sales Forecast by Country (2025-2032) & (K MT)
Table 98. South America Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Forecast by Country (2025-2032) & (M USD)
Table 99. Middle East and Africa Drugs for Duchenne Muscular Dystrophy (DMD) Consumption Forecast by Country (2025-2032) & (Units)
Table 100. Middle East and Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Forecast by Country (2025-2032) & (M USD)
Table 101. Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales Forecast by Type (2025-2032) & (K MT)
Table 102. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Forecast by Type (2025-2032) & (M USD)
Table 103. Global Drugs for Duchenne Muscular Dystrophy (DMD) Price Forecast by Type (2025-2032) & (USD/MT)
Table 104. Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales (K MT) Forecast by Application (2025-2032)
Table 105. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Drugs for Duchenne Muscular Dystrophy (DMD)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size (M USD), 2019-2032
Figure 5. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size (M USD) (2019-2032)
Figure 6. Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Country (M USD)
Figure 11. Drugs for Duchenne Muscular Dystrophy (DMD) Sales Share by Manufacturers in 2023
Figure 12. Global Drugs for Duchenne Muscular Dystrophy (DMD) Revenue Share by Manufacturers in 2023
Figure 13. Drugs for Duchenne Muscular Dystrophy (DMD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Drugs for Duchenne Muscular Dystrophy (DMD) Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Drugs for Duchenne Muscular Dystrophy (DMD) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Share by Type
Figure 18. Sales Market Share of Drugs for Duchenne Muscular Dystrophy (DMD) by Type (2019-2025)
Figure 19. Sales Market Share of Drugs for Duchenne Muscular Dystrophy (DMD) by Type in 2023
Figure 20. Market Size Share of Drugs for Duchenne Muscular Dystrophy (DMD) by Type (2019-2025)
Figure 21. Market Size Market Share of Drugs for Duchenne Muscular Dystrophy (DMD) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Share by Application
Figure 24. Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales Market Share by Application (2019-2025)
Figure 25. Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales Market Share by Application in 2023
Figure 26. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Share by Application (2019-2025)
Figure 27. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Share by Application in 2023
Figure 28. Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales Growth Rate by Application (2019-2025)
Figure 29. Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales Market Share by Region (2019-2025)
Figure 30. North America Drugs for Duchenne Muscular Dystrophy (DMD) Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Drugs for Duchenne Muscular Dystrophy (DMD) Sales Market Share by Country in 2023
Figure 32. U.S. Drugs for Duchenne Muscular Dystrophy (DMD) Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Drugs for Duchenne Muscular Dystrophy (DMD) Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Drugs for Duchenne Muscular Dystrophy (DMD) Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Sales Market Share by Country in 2023
Figure 37. Germany Drugs for Duchenne Muscular Dystrophy (DMD) Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Drugs for Duchenne Muscular Dystrophy (DMD) Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Drugs for Duchenne Muscular Dystrophy (DMD) Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Drugs for Duchenne Muscular Dystrophy (DMD) Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Drugs for Duchenne Muscular Dystrophy (DMD) Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Drugs for Duchenne Muscular Dystrophy (DMD) Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Drugs for Duchenne Muscular Dystrophy (DMD) Sales Market Share by Region in 2023
Figure 44. China Drugs for Duchenne Muscular Dystrophy (DMD) Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Drugs for Duchenne Muscular Dystrophy (DMD) Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Drugs for Duchenne Muscular Dystrophy (DMD) Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Drugs for Duchenne Muscular Dystrophy (DMD) Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Drugs for Duchenne Muscular Dystrophy (DMD) Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Drugs for Duchenne Muscular Dystrophy (DMD) Sales and Growth Rate (K MT)
Figure 50. South America Drugs for Duchenne Muscular Dystrophy (DMD) Sales Market Share by Country in 2023
Figure 51. Brazil Drugs for Duchenne Muscular Dystrophy (DMD) Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Drugs for Duchenne Muscular Dystrophy (DMD) Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Drugs for Duchenne Muscular Dystrophy (DMD) Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Drugs for Duchenne Muscular Dystrophy (DMD) Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Drugs for Duchenne Muscular Dystrophy (DMD) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Drugs for Duchenne Muscular Dystrophy (DMD) Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Drugs for Duchenne Muscular Dystrophy (DMD) Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Drugs for Duchenne Muscular Dystrophy (DMD) Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Drugs for Duchenne Muscular Dystrophy (DMD) Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Drugs for Duchenne Muscular Dystrophy (DMD) Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Drugs for Duchenne Muscular Dystrophy (DMD) Production Market Share by Region (2019-2025)
Figure 62. North America Drugs for Duchenne Muscular Dystrophy (DMD) Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Drugs for Duchenne Muscular Dystrophy (DMD) Production (K MT) Growth Rate (2019-2025)
Figure 65. China Drugs for Duchenne Muscular Dystrophy (DMD) Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Share Forecast by Type (2025-2032)
Figure 70. Global Drugs for Duchenne Muscular Dystrophy (DMD) Sales Forecast by Application (2025-2032)
Figure 71. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Share Forecast by Application (2025-2032)
Industry Market Size
